For instance, a combination of trypsin and Glu-C was used to improve the identified number of N-glycosylation sites of purified clusterin that is heavily glycosylated and upregulated in ccRCC tumors (Gbormittah et al., 2015). The gene discussed is CLU; the disease is nonpapillary renal cell carcinoma.